focus -WSS

focus

author：entertainment 2025-09-28 23:56:43 - browse：47319

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Key Senate committee drafts bipartisan bill to stem drug shortages

WSS

WHO recommends second malaria vaccine

The Karikó problem: Lessons for funding basic research

Getting Alzheimer's drug Leqembi to patients can be a challenge

FTC falls short on scrutinizing hospital mergers, study says

Health insurers' Q3 question: how much care are people getting?

Cue Health's Covid

focus

focus

focus

Virginia high school admissions case could be legal follow

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Anesthesiologist group: stop taking Ozempic before surgery

Study points to new risk in gene therapy death of Terry Horgan

How one medical school became remarkably diverse

FTC falls short on scrutinizing hospital mergers, study says

As demand for Covid shots wanes, Moderna seeks its next success

Orangutan used medicinal plant to treat wound, first time ever seen

Activists slam private health insurers over coverage restrictions

Health insurers' Q3 question: how much care are people getting?

entertainment

The biotech scorecard for Q4: 16 stock

UnitedHealth financials solid despite Change Healthcare cyberattack

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Congress extends some pandemic preparedness programs

New oral drug delivery patch is modeled after octopus tentacles

MultiPlan and major insurers sued for alleged medical price

focus

knowledge

focus

Wikipedia